Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Better look (and think) twice-TNF-alpha-inhibition and multiple sclerosis.
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
ADC evaluation of the corticospinal tract in multiple sclerosis.
Does Aquaporin-4-Seronegative Neuromyelitis Optica Exist?
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
The story of neuromyelitis optica continues to be written.
Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis.
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.
Eculizumab, Neuromyelitis Optica, and Tuberculosis: We Live An Era of Challenging Combinations.
Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis.
Telemedicine for Monitoring MS Activity and Progression.
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Seizure characteristics in multiple sclerosis patients.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF).
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.
Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide.
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.

Pages